BMC Medical Genomics:逆转艾滋病病毒易感性机制获发现

2013-07-27 张雯雯 张刚强 王超 中国科学报

近日,中科院昆明动物所的科研人员发现能够逆转艾滋病病毒-1型(HIV-1)易感性的主要靶细胞的分子机制。该研究成果发表在《BMC医学遗传学》和《国际免疫学杂志》上。该成果获得了国家自然科学基金、云南省重点项目和中科院“百人计划”的资助。 据介绍,自1981年首次发现HIV以来,虽然历经30多年的研究,但在HIV-1导致免疫缺陷的细胞和分子机理中,仍有许多关键问题不清楚。CD4+T细胞是HIV-1

近日,中科院昆明动物所的科研人员发现能够逆转艾滋病病毒-1型(HIV-1)易感性的主要靶细胞的分子机制。该研究成果发表在《BMC医学遗传学》和《国际免疫学杂志》上。该成果获得了国家自然科学基金、云南省重点项目和中科院“百人计划”的资助。

据介绍,自1981年首次发现HIV以来,虽然历经30多年的研究,但在HIV-1导致免疫缺陷的细胞和分子机理中,仍有许多关键问题不清楚。CD4+T细胞是HIV-1的主要靶细胞,在自然感染过程和通常的体外实验中,该细胞的活化和增殖是HIV-1得以大量复制的先决条件。

1996年,科学家意外发现,经过CD3/CD28抗体协同刺激后,活化的CD4+T细胞能够逆转对HIV-1的易感性。易感性是由遗传基础所决定的相同环境下不同个体患病的风险。但目前,尚不清楚这一现象所包含的调控规律和分子机制。

在该所研究员张华堂的指导下,博士研究生徐雯雯、韩妙君等采用生物芯片技术,对能够逆转HIV-1易感性的CD4+T细胞进行了全基因组分析,从中发现了产生逆转效应的信使核糖核酸(mRNA)表达谱特征。

在对数据进一步展开深入发掘和系统分析后,科研人员发现了137个核心基因在共表达网络中能够调控其他基因的表达,进而影响细胞内与细胞骨架、细胞周期和蛋白酶体等功能相关的基因的表达,最终导致逆转效应的发生。

该结果为HIV-1易感性研究提供了新思路,或将有助于进一步的临床生物标记研究。

生物谷推荐英文摘要阅读

BMC Medical Genomics 2013, 6:15 doi:10.1186/1755-8794-6-15

Genome-wide search for the genes accountable for the induced resistance to HIV-1 infection in activated CD4+ T cells: apparent transcriptional signatures, co-expression networks and possible cellular processes

Background
Upon co-stimulation with CD3/CD28 antibodies, activated CD4?+?T cells were found to lose their susceptibility to HIV-1 infection, exhibiting an induced resistant phenotype. This rather unexpected phenomenon has been repeatedly confirmed but the underlying cell and molecular mechanisms are still unknown.

Methods
We first replicated the reported system using the specified Dynal beads with PHA/IL-2-stimulated and un-stimulated cells as controls. Genome-wide expression and analysis were then performed by using Agilent whole genome microarrays and established bioinformatics tools.

Results
We showed that following CD3/CD28 co-stimulation, a homogeneous population emerged with uniform expression of activation markers CD25 and CD69 as well as a memory marker CD45RO at high levels. These cells differentially expressed 7,824 genes when compared with the controls on microarrays. Series-Cluster analysis identified 6 distinct expression profiles containing 1,345 genes as the representative signatures in the permissive and resistant cells. Of them, 245 (101 potentially permissive and 144 potentially resistant) were significant in gene ontology categories related to immune response, cell adhesion and metabolism. Co-expression networks analysis identified 137 “key regulatory” genes (84 potentially permissive and 53 potentially resistant), holding hub positions in the gene interactions. By mapping these genes on KEGG pathways, the predominance of actin cytoskeleton functions, proteasomes, and cell cycle arrest in induced resistance emerged. We also revealed an entire set of previously unreported novel genes for further mining and functional validation.

Conclusions
This initial microarray study will stimulate renewed interest in exploring this system and open new avenues for research into HIV-1 susceptibility and its reversal in target cells, serving as a foundation for the development of novel therapeutic and clinical treatments.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1858574, encodeId=a66118585e412, content=<a href='/topic/show?id=e0a9593596' target=_blank style='color:#2F92EE;'>#DIC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5935, encryptionId=e0a9593596, topicName=DIC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Thu Mar 27 11:48:00 CST 2014, time=2014-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1974564, encodeId=f12419e4564e2, content=<a href='/topic/show?id=f145355379' target=_blank style='color:#2F92EE;'>#BMC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3553, encryptionId=f145355379, topicName=BMC)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Mon Oct 07 09:48:00 CST 2013, time=2013-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077791, encodeId=598a20e7791a7, content=<a href='/topic/show?id=6f8ee950ba' target=_blank style='color:#2F92EE;'>#genomics#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7950, encryptionId=6f8ee950ba, topicName=genomics)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6eb32500176, createdName=luckyshitiancai_42705684, createdTime=Wed Aug 07 12:48:00 CST 2013, time=2013-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460501, encodeId=979e14605018c, content=<a href='/topic/show?id=36a7596628a' target=_blank style='color:#2F92EE;'>#易感性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59662, encryptionId=36a7596628a, topicName=易感性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6af6344165, createdName=FukaiBao, createdTime=Mon Jul 29 01:48:00 CST 2013, time=2013-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533540, encodeId=968a153354097, content=<a href='/topic/show?id=7583114e529' target=_blank style='color:#2F92EE;'>#Medical#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11475, encryptionId=7583114e529, topicName=Medical)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbe912466517, createdName=海豹, createdTime=Mon Jul 29 01:48:00 CST 2013, time=2013-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1548630, encodeId=9494154863019, content=<a href='/topic/show?id=8aaf868262a' target=_blank style='color:#2F92EE;'>#艾滋病病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86826, encryptionId=8aaf868262a, topicName=艾滋病病毒)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42f014104093, createdName=yige2008, createdTime=Mon Jul 29 01:48:00 CST 2013, time=2013-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605997, encodeId=44b7160599e92, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Mon Jul 29 01:48:00 CST 2013, time=2013-07-29, status=1, ipAttribution=)]
    2014-03-27 jeanqiuqiu
  2. [GetPortalCommentsPageByObjectIdResponse(id=1858574, encodeId=a66118585e412, content=<a href='/topic/show?id=e0a9593596' target=_blank style='color:#2F92EE;'>#DIC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5935, encryptionId=e0a9593596, topicName=DIC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Thu Mar 27 11:48:00 CST 2014, time=2014-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1974564, encodeId=f12419e4564e2, content=<a href='/topic/show?id=f145355379' target=_blank style='color:#2F92EE;'>#BMC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3553, encryptionId=f145355379, topicName=BMC)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Mon Oct 07 09:48:00 CST 2013, time=2013-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077791, encodeId=598a20e7791a7, content=<a href='/topic/show?id=6f8ee950ba' target=_blank style='color:#2F92EE;'>#genomics#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7950, encryptionId=6f8ee950ba, topicName=genomics)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6eb32500176, createdName=luckyshitiancai_42705684, createdTime=Wed Aug 07 12:48:00 CST 2013, time=2013-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460501, encodeId=979e14605018c, content=<a href='/topic/show?id=36a7596628a' target=_blank style='color:#2F92EE;'>#易感性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59662, encryptionId=36a7596628a, topicName=易感性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6af6344165, createdName=FukaiBao, createdTime=Mon Jul 29 01:48:00 CST 2013, time=2013-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533540, encodeId=968a153354097, content=<a href='/topic/show?id=7583114e529' target=_blank style='color:#2F92EE;'>#Medical#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11475, encryptionId=7583114e529, topicName=Medical)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbe912466517, createdName=海豹, createdTime=Mon Jul 29 01:48:00 CST 2013, time=2013-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1548630, encodeId=9494154863019, content=<a href='/topic/show?id=8aaf868262a' target=_blank style='color:#2F92EE;'>#艾滋病病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86826, encryptionId=8aaf868262a, topicName=艾滋病病毒)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42f014104093, createdName=yige2008, createdTime=Mon Jul 29 01:48:00 CST 2013, time=2013-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605997, encodeId=44b7160599e92, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Mon Jul 29 01:48:00 CST 2013, time=2013-07-29, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1858574, encodeId=a66118585e412, content=<a href='/topic/show?id=e0a9593596' target=_blank style='color:#2F92EE;'>#DIC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5935, encryptionId=e0a9593596, topicName=DIC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Thu Mar 27 11:48:00 CST 2014, time=2014-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1974564, encodeId=f12419e4564e2, content=<a href='/topic/show?id=f145355379' target=_blank style='color:#2F92EE;'>#BMC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3553, encryptionId=f145355379, topicName=BMC)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Mon Oct 07 09:48:00 CST 2013, time=2013-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077791, encodeId=598a20e7791a7, content=<a href='/topic/show?id=6f8ee950ba' target=_blank style='color:#2F92EE;'>#genomics#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7950, encryptionId=6f8ee950ba, topicName=genomics)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6eb32500176, createdName=luckyshitiancai_42705684, createdTime=Wed Aug 07 12:48:00 CST 2013, time=2013-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460501, encodeId=979e14605018c, content=<a href='/topic/show?id=36a7596628a' target=_blank style='color:#2F92EE;'>#易感性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59662, encryptionId=36a7596628a, topicName=易感性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6af6344165, createdName=FukaiBao, createdTime=Mon Jul 29 01:48:00 CST 2013, time=2013-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533540, encodeId=968a153354097, content=<a href='/topic/show?id=7583114e529' target=_blank style='color:#2F92EE;'>#Medical#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11475, encryptionId=7583114e529, topicName=Medical)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbe912466517, createdName=海豹, createdTime=Mon Jul 29 01:48:00 CST 2013, time=2013-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1548630, encodeId=9494154863019, content=<a href='/topic/show?id=8aaf868262a' target=_blank style='color:#2F92EE;'>#艾滋病病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86826, encryptionId=8aaf868262a, topicName=艾滋病病毒)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42f014104093, createdName=yige2008, createdTime=Mon Jul 29 01:48:00 CST 2013, time=2013-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605997, encodeId=44b7160599e92, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Mon Jul 29 01:48:00 CST 2013, time=2013-07-29, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1858574, encodeId=a66118585e412, content=<a href='/topic/show?id=e0a9593596' target=_blank style='color:#2F92EE;'>#DIC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5935, encryptionId=e0a9593596, topicName=DIC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Thu Mar 27 11:48:00 CST 2014, time=2014-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1974564, encodeId=f12419e4564e2, content=<a href='/topic/show?id=f145355379' target=_blank style='color:#2F92EE;'>#BMC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3553, encryptionId=f145355379, topicName=BMC)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Mon Oct 07 09:48:00 CST 2013, time=2013-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077791, encodeId=598a20e7791a7, content=<a href='/topic/show?id=6f8ee950ba' target=_blank style='color:#2F92EE;'>#genomics#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7950, encryptionId=6f8ee950ba, topicName=genomics)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6eb32500176, createdName=luckyshitiancai_42705684, createdTime=Wed Aug 07 12:48:00 CST 2013, time=2013-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460501, encodeId=979e14605018c, content=<a href='/topic/show?id=36a7596628a' target=_blank style='color:#2F92EE;'>#易感性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59662, encryptionId=36a7596628a, topicName=易感性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6af6344165, createdName=FukaiBao, createdTime=Mon Jul 29 01:48:00 CST 2013, time=2013-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533540, encodeId=968a153354097, content=<a href='/topic/show?id=7583114e529' target=_blank style='color:#2F92EE;'>#Medical#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11475, encryptionId=7583114e529, topicName=Medical)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbe912466517, createdName=海豹, createdTime=Mon Jul 29 01:48:00 CST 2013, time=2013-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1548630, encodeId=9494154863019, content=<a href='/topic/show?id=8aaf868262a' target=_blank style='color:#2F92EE;'>#艾滋病病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86826, encryptionId=8aaf868262a, topicName=艾滋病病毒)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42f014104093, createdName=yige2008, createdTime=Mon Jul 29 01:48:00 CST 2013, time=2013-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605997, encodeId=44b7160599e92, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Mon Jul 29 01:48:00 CST 2013, time=2013-07-29, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1858574, encodeId=a66118585e412, content=<a href='/topic/show?id=e0a9593596' target=_blank style='color:#2F92EE;'>#DIC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5935, encryptionId=e0a9593596, topicName=DIC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Thu Mar 27 11:48:00 CST 2014, time=2014-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1974564, encodeId=f12419e4564e2, content=<a href='/topic/show?id=f145355379' target=_blank style='color:#2F92EE;'>#BMC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3553, encryptionId=f145355379, topicName=BMC)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Mon Oct 07 09:48:00 CST 2013, time=2013-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077791, encodeId=598a20e7791a7, content=<a href='/topic/show?id=6f8ee950ba' target=_blank style='color:#2F92EE;'>#genomics#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7950, encryptionId=6f8ee950ba, topicName=genomics)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6eb32500176, createdName=luckyshitiancai_42705684, createdTime=Wed Aug 07 12:48:00 CST 2013, time=2013-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460501, encodeId=979e14605018c, content=<a href='/topic/show?id=36a7596628a' target=_blank style='color:#2F92EE;'>#易感性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59662, encryptionId=36a7596628a, topicName=易感性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6af6344165, createdName=FukaiBao, createdTime=Mon Jul 29 01:48:00 CST 2013, time=2013-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533540, encodeId=968a153354097, content=<a href='/topic/show?id=7583114e529' target=_blank style='color:#2F92EE;'>#Medical#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11475, encryptionId=7583114e529, topicName=Medical)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbe912466517, createdName=海豹, createdTime=Mon Jul 29 01:48:00 CST 2013, time=2013-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1548630, encodeId=9494154863019, content=<a href='/topic/show?id=8aaf868262a' target=_blank style='color:#2F92EE;'>#艾滋病病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86826, encryptionId=8aaf868262a, topicName=艾滋病病毒)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42f014104093, createdName=yige2008, createdTime=Mon Jul 29 01:48:00 CST 2013, time=2013-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605997, encodeId=44b7160599e92, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Mon Jul 29 01:48:00 CST 2013, time=2013-07-29, status=1, ipAttribution=)]
    2013-07-29 海豹
  6. [GetPortalCommentsPageByObjectIdResponse(id=1858574, encodeId=a66118585e412, content=<a href='/topic/show?id=e0a9593596' target=_blank style='color:#2F92EE;'>#DIC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5935, encryptionId=e0a9593596, topicName=DIC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Thu Mar 27 11:48:00 CST 2014, time=2014-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1974564, encodeId=f12419e4564e2, content=<a href='/topic/show?id=f145355379' target=_blank style='color:#2F92EE;'>#BMC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3553, encryptionId=f145355379, topicName=BMC)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Mon Oct 07 09:48:00 CST 2013, time=2013-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077791, encodeId=598a20e7791a7, content=<a href='/topic/show?id=6f8ee950ba' target=_blank style='color:#2F92EE;'>#genomics#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7950, encryptionId=6f8ee950ba, topicName=genomics)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6eb32500176, createdName=luckyshitiancai_42705684, createdTime=Wed Aug 07 12:48:00 CST 2013, time=2013-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460501, encodeId=979e14605018c, content=<a href='/topic/show?id=36a7596628a' target=_blank style='color:#2F92EE;'>#易感性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59662, encryptionId=36a7596628a, topicName=易感性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6af6344165, createdName=FukaiBao, createdTime=Mon Jul 29 01:48:00 CST 2013, time=2013-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533540, encodeId=968a153354097, content=<a href='/topic/show?id=7583114e529' target=_blank style='color:#2F92EE;'>#Medical#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11475, encryptionId=7583114e529, topicName=Medical)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbe912466517, createdName=海豹, createdTime=Mon Jul 29 01:48:00 CST 2013, time=2013-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1548630, encodeId=9494154863019, content=<a href='/topic/show?id=8aaf868262a' target=_blank style='color:#2F92EE;'>#艾滋病病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86826, encryptionId=8aaf868262a, topicName=艾滋病病毒)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42f014104093, createdName=yige2008, createdTime=Mon Jul 29 01:48:00 CST 2013, time=2013-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605997, encodeId=44b7160599e92, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Mon Jul 29 01:48:00 CST 2013, time=2013-07-29, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1858574, encodeId=a66118585e412, content=<a href='/topic/show?id=e0a9593596' target=_blank style='color:#2F92EE;'>#DIC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5935, encryptionId=e0a9593596, topicName=DIC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Thu Mar 27 11:48:00 CST 2014, time=2014-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1974564, encodeId=f12419e4564e2, content=<a href='/topic/show?id=f145355379' target=_blank style='color:#2F92EE;'>#BMC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3553, encryptionId=f145355379, topicName=BMC)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Mon Oct 07 09:48:00 CST 2013, time=2013-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2077791, encodeId=598a20e7791a7, content=<a href='/topic/show?id=6f8ee950ba' target=_blank style='color:#2F92EE;'>#genomics#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7950, encryptionId=6f8ee950ba, topicName=genomics)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6eb32500176, createdName=luckyshitiancai_42705684, createdTime=Wed Aug 07 12:48:00 CST 2013, time=2013-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1460501, encodeId=979e14605018c, content=<a href='/topic/show?id=36a7596628a' target=_blank style='color:#2F92EE;'>#易感性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59662, encryptionId=36a7596628a, topicName=易感性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6af6344165, createdName=FukaiBao, createdTime=Mon Jul 29 01:48:00 CST 2013, time=2013-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533540, encodeId=968a153354097, content=<a href='/topic/show?id=7583114e529' target=_blank style='color:#2F92EE;'>#Medical#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11475, encryptionId=7583114e529, topicName=Medical)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cbe912466517, createdName=海豹, createdTime=Mon Jul 29 01:48:00 CST 2013, time=2013-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1548630, encodeId=9494154863019, content=<a href='/topic/show?id=8aaf868262a' target=_blank style='color:#2F92EE;'>#艾滋病病毒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86826, encryptionId=8aaf868262a, topicName=艾滋病病毒)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42f014104093, createdName=yige2008, createdTime=Mon Jul 29 01:48:00 CST 2013, time=2013-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605997, encodeId=44b7160599e92, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Mon Jul 29 01:48:00 CST 2013, time=2013-07-29, status=1, ipAttribution=)]

相关资讯

青年学生染艾人数呈上升趋势

  国家卫生和计划生育委员会疾病预防控制局局长于竞进30日表示,2012年发现的艾滋病病毒感染者和病人中,青年学生感染人数呈上升趋势,当年新发现1700例,较2011年上升24.5%。   于竞进是在当日举行的“青春红丝带”——进校园、进社区、进工地“三进”防艾宣传教育活动启动仪式上作上述表示的。这项由共青团中央主办的活动将深入校园、社区和工地,广泛宣传艾滋病知识,号召更多人关注并参与艾滋病防治

艾滋病疫苗载体被证有毒

     对一项大型HIV疫苗实验进行的分析显示,该疫苗并没有疗效,攻克HIV的希望又破灭了。   近日,两项实验的毁灭性结果再次使研究人员对艾滋病病毒(HIV)疫苗战略的评估陷入混乱,而一个广泛应用于疫苗和基因治疗研究的载体也因此引起了他们的担忧。这样的双重打击表明,疫苗作为减缓艾滋病流行的最有效方法,其成功研制仍任重道远。   4月22日,第一个坏消息传来。一个监督正在进行的最大的HIV

J Virol:我国艾滋病感染粘膜疫苗研究取得重大进展

清华大学医学院张林琦教授主持的艾滋病疫苗研究取得重大进展。日前,张林琦领导的研究团队在国际权威杂志《病毒学》上发表了题为《粘膜免疫复制型载体艾滋病疫苗可有效控制猴艾滋病毒致病》的研究论文,在世界上首次报道了联合使用复制性痘苗病毒载体和粘膜途径初次免疫的创新型艾滋病疫苗战略,为疫苗进一步优化和人体试验打下了基础。 虽然粘膜作为感染艾滋病的主要器官,但还没有进入临床试验的针对艾滋病感染的粘膜疫苗。“

PLoS ONE:特定润滑剂的使用并不会增加艾滋病感染风险

近日,刊登在国际杂志PLoS One上的一篇研究报告揭示了,水性、非处方的个体润滑剂(可刺激阴道、直肠,使其兴奋)并不会增加HIV的易感性,尽管如此,研究者表示还需要进行深入研究来评估个体润滑剂的安全性以及对上皮组织的副作用。 研究者Charlene S. Dezzutti说,我们检测了许多种类的个人润滑剂,其对组织的损伤唯一一点就是高渗透性。尽管我们知道细胞毒性和高渗透性的润滑剂有关,但是这种

J Vir:我国艾滋病疫苗能有效控制HIV病毒通过粘膜途径感染

  预防和控制艾滋病传播的最有效措施为研发出有效的疫苗,但这项课题一直被视为很难攻克的世界性科学难题。中国科学院广州生物医药与健康研究院、清华大学和香港大学的科学家们经过5年多的不懈努力,精诚合作,艰苦创新,终于在这一方面取得具有突破意义的科研成果。   首次报道发明了一种创新性的艾滋病疫苗策略,通过联合使用改良型痘苗病毒天坛株(MVTT)黏膜载体疫苗和5型腺病毒载体疫苗(Ad5),能有效控制甚

Lancet :研究称泰诺福韦可降低吸毒者感染艾滋病毒风险

泰国和美国的最新联合研究成果显示,每日定时服用抗逆转录病毒药物泰诺福韦,可有效降低通过注射方式吸毒者感染艾滋病病毒的风险。 这一研究项目由泰国卫生部、美国疾病控制和预防中心研究人员从2005年开始共同实施。报告已发表在英国《柳叶刀》杂志上。